Although the precise incidence of 17βHSD-3<unk>  is unknown, a recent study from the Netherlands estimated the incidence around 1 in 147,000 newborns, with a calculated heterozygote frequency of 1 in 135.
17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics
17 alpha-hydroxylase deficiency epidemiology and demographics
11β-hydroxylase deficiency epidemiology and demographics
21-hydroxylase deficiency epidemiology and demographics
Androgen insensitivity syndrome epidemiology and demographics
17 alpha-hydroxylase deficiency MRI
21-hydroxylase deficiency laboratory findings
Multiple endocrine neoplasia type 1 pathophysiology